BSMHIGH SIGNALFINANCIAL10-K

BSM experienced a dramatic decline in accounts receivable alongside significantly reduced interest expense, suggesting major changes in business operations or accounting treatment.

The near-complete elimination of accounts receivable (dropping to just $2.9M from $71.1M) is highly unusual and could indicate collection issues, changes in revenue recognition, or a shift in business model. The substantially lower interest expense suggests debt reduction or refinancing, while the decline in net income despite higher operating income indicates significant non-operating impacts that warrant investor scrutiny.

Comparing 2026-02-24 vs 2025-02-25View on EDGAR →
FINANCIAL ANALYSIS

BSM's financial profile shows mixed signals with operating income growing modestly to $308.4M while net income declined to $271.3M, indicating non-operating headwinds. The balance sheet transformation is striking, with accounts receivable nearly eliminated and current assets still growing 21.8% despite this reduction, while current liabilities decreased 19.1%. The substantially reduced interest expense and lower operating cash flow of $310.2M suggest significant structural changes in the company's financial operations that require careful analysis.

FINANCIAL STATEMENT CHANGES
Accounts Receivable
Balance Sheet
-95.9%
$71.1M$2.9M

Receivables declined — improved collection efficiency or conservative revenue recognition.

Interest Expense
P&L
-56.2%
$6.3M$2.8M

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Cash & Equivalents
Balance Sheet
-41.3%
$2.5M$1.5M

Cash declined 41.3% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Net Income
P&L
-35.8%
$422.5M$271.3M

Net income declined 35.8% — review whether driven by operations, interest costs, or non-recurring items.

Current Assets
Balance Sheet
+21.8%
$78.5M$95.6M

Current assets grew 21.8% — improving short-term liquidity or inventory/receivables build.

Operating Cash Flow
Cash Flow
-20.3%
$389.0M$310.2M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

Current Liabilities
Balance Sheet
-19.1%
$30.4M$24.6M

Current liabilities reduced — improved short-term financial position and working capital health.

Operating Income
P&L
+12.9%
$273.1M$308.4M

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

LANGUAGE CHANGES
NEW — 2026-02-24
PRIOR — 2025-02-25
ADDED
As of February 20, 2026, 212,333,793 common units and 14,711,219 Series B cumulative convertible preferred units of the registrant were outstanding.
We own mineral interests in approximately 16.9 million gross acres, with an aver age 43.4% ownership interest in that acreage.
Of our total reserves as of December 31, 2025, approxima tely 88% w ere proved developed reserves and approxima tely 12% we re proved undeveloped reserves.
We have farmout arrangements in place for our entire working interest position in that area.
Working interest production represented 4% of our total production volumes during the year ended December 31, 2025.
+7 more — sign up free →
REMOVED
As of February 21, 2025, 211,137,816 common units and 14,711,219 Series B cumulative convertible preferred units of the registrant were outstanding.
We own mineral interests in approximately 16.8 million gross acres, with an aver age 43.3% ownership interest in that acreage.
Of our total reserves as of December 31, 2024, approxima tely 95% w ere proved developed reserves and approxima tely 5% we re proved undeveloped reserves.
We have farmout arrangements in place for a portion of our working interest position in that area and do not intend to step into the remaining working interest position.
Working interest production represented 5% of our total production volumes during the year ended December 31, 2024.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →